---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-24-000640"
form_type: "8-K"
ticker: "PDEX"
cik: "0000788920"
company_name: "PRO DEX INC"
filed_at: "2024-05-02T23:59:59+00:00"
generated_at: "2026-06-03T01:13:34.549902+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pro-Dex Q3 revenue up 9% to $14.3M; net income falls to $0.19 EPS on investment losses

## Summary
- Net sales $14.3M (+9% YoY); operating income $2.2M (+7%) driven by medical device revenue.
- Net income $655k ($0.19 diluted EPS) vs $1.6M ($0.45) prior year; decline due to $1.2M unrealized loss on investments.
- Nine-month net sales $38.8M (+10%); operating income $4.8M (+16%).
- Nine-month net income $540k ($0.15 diluted EPS) vs $5.6M ($1.52) due to $3.8M unrealized investment losses.
- CEO Rick Van Kirk says company tracking toward record revenue year; confident in momentum into FY2025.

## SEC filing metadata
- accession: 0001079973-24-000640
- form_type: 8-K
- ticker: PDEX
- cik: 0000788920
- company_name: PRO DEX INC
- filed_at: 2024-05-02T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/788920/000107997324000640/0001079973-24-000640-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/788920/000107997324000640/pdex_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-24-000640
- JSON: https://secwatch.observer/filing/0001079973-24-000640.json
- Plain text: https://secwatch.observer/filing/0001079973-24-000640.txt

## Key facts
- Earnings Releases
  PRO DEX INC reported third quarter ended March 31, 2024 results: revenue $14.3 million, net income $655,000, or $0.19 per diluted share, EPS $0.19 per diluted share.
  - Period: third quarter ended March 31, 2024
  - Revenue: $14.3 million
  - Net income: $655,000, or $0.19 per diluted share
  - EPS: $0.19 per diluted share
  - Result: reported results
  source text: Net sales for the three months ended March 31, 2024, increased $1.2 million, or 9%, to $14.3 million from $13.1 million for the three months ended March 31, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/788920/000107997324000640/0001079973-24-000640-index.htm
- Earnings Releases
  PRO DEX INC reported nine months ended March 31, 2024 results: revenue $38.8 million, net income $540,000, or $0.15 per diluted share, EPS $0.15 per diluted share.
  - Period: nine months ended March 31, 2024
  - Revenue: $38.8 million
  - Net income: $540,000, or $0.15 per diluted share
  - EPS: $0.15 per diluted share
  - Result: reported results
  source text: Net sales for the nine months ended March 31, 2024, increased $3.4 million, or 10%, to $38.8 million from $35.4 million for the nine months ended March 31, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/788920/000107997324000640/0001079973-24-000640-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.